Patent details

Basic Information

Publication number:

EP2513058

PCT Application Number:

PCT/US/2010/060572

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP108014952

PCT Publication Number:

WO/2011/084519

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

METHODS OF SYNTHESIZING FACTOR XA INHIBITORS

French Title of Invention:

PROCÉDÉS DE SYNTHÈSE D'INHIBITEURS DU FACTEUR XA

German Title of Invention:

VERFAHREN ZUR SYNTHESE VON FAKTOR-XA-HEMMERN

SPC Number:

Dates

Filing date:

15/12/2010

Grant date:

09/11/2016

EP Publication Date:

09/11/2016

PCT Publication Date:

14/07/2011

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

24/10/2012

EP B1 Publication Date:

09/11/2016

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

15/12/2016

Expiration date:

15/12/2030

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

15/12/2010

 

 

Name:

Millennium Pharmaceuticals Inc.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Name:

Portola Pharmaceuticals Inc.

Address:

270 East Grand Avenue Suite 22, South San Francisco, California 94080, United States (US)

Inventor

1

Name:

SONG Zhiguo, Jake

Address:

United States (US)

2

Name:

LEITAO Emilia, P., T.

Address:

Portugal (PT)

3

Name:

RATO Jose

Address:

Portugal (PT)

4

Name:

PANDEY Anjali

Address:

United States (US)

Priority

Priority Number:

287680 P

Priority Date:

17/12/2009

Priority Country:

United States (US)

Classification

Main IPC Class:

C07D 213/75;

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages